Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LCH-IV
2011-001699-20Phase 3Active
- Sponsor
- St. Anna Children's Cancer Research Institute
- Start
- Apr 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of vinblastine, prednisolone, mercaptopurine, methotrexate, cladribine and 6 more in Langerhans cell histiocytosis (LCH), sponsored by St. Anna Children's Cancer Research Institute. Primary endpoints: Reduction of mortality in multi-system LCH and Validation of disease activity and response score. Started Apr 2012; status: active.
02
Drugs
vinblastineprednisolonemercaptopurinemethotrexatecladribine
03
Conditions
Langerhans cell histiocytosis (LCH)
Beyond the preview
Go deeper on 2011-001699-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001699-20.